The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMJH.L Regulatory News (MJH)

  • There is currently no data for MJH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Progressive publishes new research

19 May 2022 07:00

RNS Number : 0286M
MJ Hudson Group PLC
19 May 2022
 

Market's questions answered

 

MJ Hudson's Q3 FY22 trading update, issued on Thursday 12 May, revealed that the company's results for the full year are expected to be significantly ahead of our, and the market's, expectations. Adjusted EBITDA for the year is expected to be at least £8.3m, against our estimate of £7.5m and a prior-year figure of £5.6m. We have adjusted our forecasts for both FY22 and FY23 following this statement (see table overleaf), with our FY23 Adjusted EBITDA estimate going from £9.0m to £10.5m. The key drivers to the strong performance are the company's 'three transformative growth areas': ESG & Sustainability, the Irish Super ManCo and Luxembourg fund services.

 

Click here for full analysis

 

Subscribe to Progressive's research, which is freely available to every type of investor, and be kept informed about our regular programme of investor engagement. 

About Progressive:

Progressive helps you make informed investment decisions. FCA authorised and regulated, and with a 15-strong team of highly experienced analysts, we provide freely available institutional grade equity research and access to company management teams across every sector of the market.

 

www.progressive-research.com

 

Broad coverage

 

Analyst calibre

 

across 12 sectors

 

Business Services

Oil & Gas

15 analysts

with average

20 years

Financials

Property

experience of

Healthcare

Retail

 

Industrials

Technology

30+

 

techMARK

Investment Trusts

Telecoms

industry based

Extel

Mining

Utilities

awards

StarMine

 

 

For further information please contact: 

Keith Hodgskiss

+44 (0) 20 7781 5300

khodgskiss@progressive-research.com

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRASFEEEAEESEEI
Date   Source Headline
13th Jul 20207:00 amRNSEmployee Benefit Trust Dealings
1st Jun 20207:00 amRNSTrading Statement
26th May 20207:57 amRNSHolding(s) in Company
24th Apr 20204:03 pmRNSHolding(s) in Company
6th Apr 20205:26 pmRNSDirector/PDMR Shareholding
18th Mar 20207:01 amRNSInterim Results
18th Mar 20207:00 amRNSAcquisition of Meyler LLC
3rd Feb 20207:00 amRNSFurther re. acquisition of Anglo Saxon Trust
14th Jan 20207:00 amRNSPre-close Interim Trading Update
16th Dec 20194:11 pmRNSHolding(s) in Company
12th Dec 20193:14 pmRNSHolding(s) in Company
12th Dec 20197:00 amRNSAdmission to trading on AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.